Payal Kohli, MD

VARIOUS

9020 WALKING STICK TRL

Articles

Women and Heart Disease: Incidence, Prevalence, Progress, and the Future

April 06, 2013

Female CV mortality lags behind male mortality; lifetime risk assessment, not 10-year risk, is a better estimation tool for women

The Mediterranean Diet in Primary Cardiovascular Prevention

March 20, 2013

Patients who consumed a Mediterranean-style diet had a 30% reduction in major cardiovascular events compared with patients who ate a diet low in saturated fat.

Beta-Blockers in Heart Failure Patients With Atrial Fibrillation: Do They Really Save Lives?

March 13, 2013

A recent meta-analysis of beta-blocker use in patients with HF found that the drugs conferred no reduction in rates of mortality or hospitalization among patients with comorbid AF.

DPP-4 Antagonists: Benefits, Risks, and the Future

February 26, 2013

Dipeptidyl peptidase-4 inhibitors, of the incretin class of antidiabetes drugs, are weight neutral, avoid hypoglycemia, and result in an average reduction in HbA1c of 0.5% to 1.0%

Lipid-lowering Injectable Antibodies: The Next Big Thing?

November 29, 2012

PCSK-9 inhibition in patients with recalcitrant hypercholesterolemia has reaped reductions in LDL-C of up to 85% after the first week of therapy.

Who Needs Beta-Blockers? Analysis Raises Questions

October 24, 2012

A new analysis of data from a large international registry finds that use of beta-blockers in patients with and without a history of coronary artery disease does not reduce cardiovascular events.

Myocardial Infarction: New Meaning, Same Name

October 13, 2012

In 2000, MI was defined as any necrosis in the setting of myocardial ischemia. The 2007 update to this definition recognized that different conditions can lead to myocardial necrosis and 5 types of myocardial infarctions were defined.

The “Statin-Intolerant” Patient: Alternative Strategies for Primary Care

September 27, 2012

In patients deemed statin-intolerant, lifestyle changes and alternative classes of drugs should be pursued to lower LDL-C.